(Q41047747)

26 September 2017

1 reference

title

Antibacterial activity of quinupristin/dalfopristin. Rationale for clinical use. (English)

1 reference

26 September 2017

R G Finch

1

1 reference

26 September 2017

publication date

1 January 1996

1 reference

26 September 2017

1 reference

26 September 2017

volume

51 Suppl 1

1 reference

26 September 2017

page(s)

31-37

1 reference

Bactericidal activity and kinetics of RP 59500 in a mouse model of Staphylococcus aureus septicaemia

26 September 2017

cites work

1 reference

12 December 2020

RP 59500, a new streptogramin highly active against recent isolates of North American staphylococci

1 reference

12 December 2020

In vitro activity of RP 59500, a semisynthetic injectable pristinamycin, against staphylococci, streptococci, and enterococci

1 reference

12 December 2020

New forms and new needs may make macrolides antibiotics of the decade

1 reference

12 December 2020

In vitro activities of a streptogramin (RP59500), three macrolides, and an azalide against four respiratory tract pathogens

1 reference

12 December 2020

Susceptibilities of penicillin-susceptible and -resistant strains of Streptococcus pneumoniae to RP 59500, vancomycin, erythromycin, PD 131628, sparfloxacin, temafloxacin, win 57273, ofloxacin, and ciprofloxacin

1 reference

12 December 2020

Studies of RP 59500 in vitro and in a rabbit model of aortic valve endocarditis caused by methicillin-resistant Staphylococcus aureus

1 reference

12 December 2020

In vitro antistaphylococcal activity and testing of RP 59500, a new streptogramin, by two methods

1 reference

12 December 2020

Pharmacodynamics of RP 59500 alone and in combination with vancomycin against Staphylococcus aureus in an in vitro-infected fibrin clot model

1 reference

12 December 2020

In-vitro antibacterial activity of RP 59500, a semisynthetic streptogramin, against Streptococcus pneumoniae

1 reference

12 December 2020

Comparative in-vitro activity of RP 59500

1 reference

12 December 2020

RP 59500 prophylaxis of experimental endocarditis due to erythromycin-susceptible and -resistant isogenic pairs of viridans group streptococci

1 reference

12 December 2020

Study of comparative antipneumococcal activities of penicillin G, RP 59500, erythromycin, sparfloxacin, ciprofloxacin, and vancomycin by using time-kill methodology

1 reference

12 December 2020

In vitro activity of RP 59500 (quinupristin/dalfopristin) against antibiotic-resistant strains of Streptococcus pneumoniae and enterococci.

1 reference

12 December 2020

In vitro activity of RP59500, an injectable streptogramin antibiotic, against vancomycin-resistant gram-positive organisms

1 reference

12 December 2020

Post-antibiotic effects of RP 59500 with Staphylococcus aureus

1 reference

12 December 2020

Susceptibility of 539 gram-positive and gram-negative anaerobes to new agents, including RP59500, biapenem, trospectomycin and piperacillin/tazobactam

1 reference

12 December 2020

In vivo activities and penetration of the two components of the streptogramin RP 59500 in cardiac vegetations of experimental endocarditis

1 reference

12 December 2020

In-vitro activity of streptogramin RP 59500 against staphylococci, including bactericidal kinetic studies

1 reference

12 December 2020

The postantibiotic effect of RP 59500 on Staphylococcus aureus including strains with a raised MBC

1 reference

12 December 2020

Comparative in-vitro activity of RP 59500 against clinical bacterial isolates

1 reference

12 December 2020

Activity of RP 59500, a new parenteral semisynthetic streptogramin, against staphylococci with various mechanisms of resistance to macrolide-lincosamide-streptogramin antibiotics.

1 reference

12 December 2020

The in-vitro activity of a new semi-synthetic streptogramin compound, RP 59500, against staphylococci and respiratory pathogens

1 reference

12 December 2020

The in-vitro activity of new streptogramins, RP 59500, RP 57669 and RP 54476, alone and in combination

1 reference

12 December 2020

The in-vitro activity of RP 59500 against gram-positive cocci

1 reference

12 December 2020

In vitro antimicrobial susceptibility of glycopeptide-resistant enterococci.

1 reference

12 December 2020

Post-antibiotic effect of the new streptogramin RP 59500.

1 reference

12 December 2020

Susceptibility of anaerobic bacteria to the new streptogramin RP 59500 in vitro

1 reference

12 December 2020

10.2165/00003495-199600511-00007

Identifiers

DOI

0 references

1 reference